Always check the Praluent label before each injection to make sure you are using . The U.S. Food and Drug Administration (FDA) recently approved Praluent (alirocumab) and Repatha (evolocumab), the first cholesterol-lowering injection treatments in the new class of PCSK9 inhibitors. Limited post-hoc data suggest that . French drugmaker Sanofi and U.S. partner Regeneron said a late-stage study of their Praluent injection showed it reduced the need for patients with an inherited form of high cholesterol to have bad cholesterol removed from their blood. These drugs work by helping to remove LDL cholesterol from the blood. Praluent is indicated for the treatment of adults with high low-density lipoprotein (LDL) cholesterol, as well as an adjunct to diet and maximally tolerated statin therapy in adults . Sanofi and Regeneron Announce 18,000-Patient ODYSSEY OUTCOMESTrial of Praluent ® (alirocumab) Injection Fully Enrolled. Alirocumab was also associated with a 15 percent reduction in death from any cause, marking the first evidence that this relatively new class of drugs, called PCSK9 inhibitors, can . When they're prescribed • To administer the 300 mg dose, give two 150 mg PRALUENT injections consecutively at two different injection sites. Alirocumab (Praluent) Evolocumab (Repatha) Decrease LDL; usually reserved for people who have a genetic condition that causes very high LDL levels or people with heart disease who cannot tolerate statins or other cholesterol lowering drugs : Itching, swelling, pain or bruising at injection site: Citrate lyase inhibitors Bempedoic acid (Nexletol) These drugs . Satisfaction. Praluent 75 mg solution for injection in pre-filled pen. To administer the 300 mg dose, give two 150 mg PRALUENT injections consecutively at two different injection sites. /PRNewswire/ -- Sanofi and Regeneron Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) approved Praluent® (alirocumab). The PCSK9 inhibitor alirocumab (Praluent) given by subcutaneous injection every 2 weeks can further lower LDL-cholesterol levels by 40% or more in patients with heterozygous familial hypercholesterolemia or clinical atherosclerotic cardiovascular disease already taking maximally tolerated doses of a statin . Praluent (alirocumab) is an expensive injectable medication used to treat high cholesterol and lower the risk of heart attack and stroke. Each pre-filled pen with green button contains 1 ml of solution, delivering one single dose of 75 milligrams of alirocumab. Known side effects for Praluent are itching, swelling, pain and/or bruising at the injection . • Rotate the injection site with each injection. Limited post-hoc data suggest that . Change the place that you inject each time so that you do not become sore in one area. Praluent, marketed by Sanofi-Aventis and Regeneron Pharmaceuticals, is approved for use, in addition to diet and the maximum tolerated statin dose, in adults with a condition called heterozygous familial hypercholesterolemia (HeFH) or in those with atherosclerotic heart disease such as heart attacks or strokes who require additional lowering of LDL cholesterol. Regeneron Pharmaceuticals Inc. It is created by eHealthMe based on reports of 19,635 people who have side effects when taking Praluent from the FDA, and is updated regularly. Frequently Asked Questions (FAQs) on Praluent: Solution for injection. Alirocumab, sold under the brand name Praluent, is a medication used as a second-line treatment for high cholesterol for adults whose cholesterol is not controlled by diet and statin treatment. It's given as a subcutaneous injection. The FDA approved Praluent for two groups of patients at highest risk of heart problems: Remove Repatha from your drug comparison. Praluent is indicated for the treatment of adults with high low-density lipoprotein (LDL) cholesterol, as well as an adjunct to diet and maximally tolerated statin therapy in adults . Three years ago, the FDA approved two drugs that lower harmful LDL cholesterol values dramatically — by more than 50%. Alirocumab Approved for Heterozygous Familial Hypercholesterolemia. PRALUENT is an injection that is given under the skin in the thigh, abdomen, or upper arm once every two weeks. The FDA has approved Sanofi and Regeneron's new supplemental biologics license application for a once-monthly, 300-mg dose of Praluent (alirocumab) injection. The major side effects of Praluent include nose and throat irritation, redness, swelling, itching and pain at the injection site and flu-like symptoms. . The drug was discovered by Regeneron Pharmaceuticals and is being developed in collaboration with Sanofi US. After 4 injections my total cholesterol went down from 176 to 109 and LDL from 123 to 29. For Adult. Filter by condition. The anti-cholesterol drug Praluent (alirocumab), made by France's Sanofi Pharmaceuticals, is linked to a 15 percent lower risk of major cardiovascular events like heart attack and stroke, a study . The phase IV clinical study analyzes which people take Praluent and have Dry skin. 1. of 1 | next >. 4 CONTRAINDICATIONS . Learn about side effects and more of Praluent (alirocumab), a prescription injection used to lower cholesterol and the risk of certain cardiovascular problems. In July 2015, the FDA approved alirocumab injection (Praluent, Regeneron/Sanofi), the first cholesterol-lowering treatment in a new class of drugs known as proprotein convertase subtilisin kexin type 9 (PCSK9) inhibitors. It will become the first fully-human monoclonal antibody targeting PCSK9 (proprotein convertase subtilisin / kexin type 9) in the US, if approved. It is recommended to rotate the injection site with each injection. "This is the first time a PCSK9 inhibitor has shown in a clinical study that it reduced the frequency of apheresis therapy, an invasive, difficult to access . Side effects, drug interactions, dosage, storage, and pregnancy and breastfeeding safety information is provided. Cholesterol-lowering drugs known as PCSK9 inhibitors may improve the effectiveness of cancer immune checkpoint inhibitors, according to studies in mice. Praluent 75mg along with Lipitor statin 20mg lowered my LDL bad cholesterol from 200 down to 40 in 3 months without any side effects so far. Medication Pearl of the Day: Alirocumab (Praluent) Indication: Alirocumab(Praluent) is a proprotein convertase subtilisin kexin type 9 (PCSK9) inhibitor antibody indicated as adjunct to diet and maximally tolerated statin therapy for the treatment of adults with heterozygous familial hypercholesterolemia or clinical atherosclerotic . (Repatha) and alirocumab (Praluent), were approved in the United States in 2015. . This drug may also be used to reduce the risk of heart attack, stroke, and . I need this medication bcz I already had 2 heart attacks . < previous | page. Praluent alirocumab. . Repatha evolocumab. Praluent is one of a new class of cholesterol-reducing medications called PCSK9, that are being developed by a number of pharmaceutical companies, that could drastically reduce LDL (bad cholesterol) levels in some patients with high cholesterol. PCSK9 inhibitors require injections every 2 to 4 weeks in a . It is available in pack size of 1, 2 or 6 pre-filled pens. PRALUENT lowers LDL cholesterol. Learn about the reported side effects, related class drugs, and how these medications will affect your daily lifestyle. It is used along with diet and statin drugs in adults with heterozygous familial hypercholesterolemia (an inherited condition that causes high levels of LDL) or atherosclerotic heart problems, who need additional lowering of LDL cholesterol. Praluent comes as a liquid solution in a single-dose prefilled pen. available to clear LDL, thereby lowering LDL cholesterol levels. This medicine is only for patients whose cholesterol is not controlled by diet and statin therapy. Praluent was the first PCSK9 (proprotein convertase subtilisin/kexin type 9) inhibitor approved by the FDA and is the only PCSK9 inhibitor available in two doses with two levels of efficacy as a single 1 mL injection (75 mg and 150 mg) once every two weeks. Initially 75 mg every 2 weeks; increased if necessary to 150 mg every 2 weeks, alternatively 300 mg every 4 weeks, patients requiring an LDL-C reduction of greater than 60% may be initiated on 150 mg every 2 weeks or 300 mg every 4 weeks, dose adjustments should be made at 4 to 8 weekly intervals. PRALUENT 75 mg/mL or 150 mg/mL solution for subcutaneous injection in a single-dose pre-filled pen is supplied in a siliconized 1 mL Type-1 clear glass syringe. [4/1/2021] FDA has approved Praluent (alirocumab) injection for adult patients with homozygous familial hypercholesterolemia (HoFH), a genetic condition that causes severely high cholesterol . By subcutaneous injection. PRALUENT is contraindicated in patients with a history of a serious hypersensitivity reaction to alirocumab or any of the excipients in PRALUENT. The medicine can only be obtained with a prescription. Remove Praluent from your drug comparison. . Learn about side effects and more. How are PCSK9 inhibitors given when treating high cholesterol? 7 Alirocumab was approved for use as an adjunct to diet and maximally tolerated statin therapy in adults with heterozygous . Packager: Sanofi US Corporation. Learn more about Praluent here. • Administer PRALUENT by subcutaneous injection into the thigh, abdomen, or upper arm using a single-dose pre-filled pen or single-dose pre-filled syringe. Alirocumab belongs to a class of drugs known as monoclonal antibodies . 20 results/pg 50 results/pg 100 results/pg 200 results/pg. PCSK9-inhibiting drugs are showing promise as an alternative treatment for high cholesterol. latest videos on Cholesterol Management. Praluent and a similar drug, Amgen's Repatha, work in a different way and lower cholesterol much more. The . Praluent is a brand (trade) name for alirocumab which is a human monoclonal antibody that may be used to treat high cholesterol. Add another drug to compare. Praluent (alirocumab) is a PCSK9 inhibitor. User Reviews for Praluent to treat High Cholesterol. This condition can cause high blood . They're both prescribed to lower cholesterol levels.They also both reduce the risk of heart attack and stroke in people with heart disease.. To administer the 300 mg dose, either one 300 mg injection or two 150 mg injections should be given consecutively at two different injection sites. Find everything you need to know about Praluent Pen, including what it is used for, warnings, reviews, side effects, and interactions. (Praluent) Alirocumab (Praluent . Paris and Tarrytown, New York - November 24, 2015-Sanofi and Regeneron Pharmaceuticals, Inc. today announced that the companies have completed enrollment in the global Phase 3 ODYSSEY OUTCOMES trial, which is prospectively evaluating the potential cardiovascular (CV . What are the benefits of this drug? It is a human monoclonal antibody that belongs to a novel class of anti-cholesterol drugs, known as PCSK9 inhibitors, and it was the first such agent to receive FDA approval. PCSK9 inhibitors are given by injection only. Praluent is a new injectable drug approved by the FDA to lower cholesterol. Injection sites include the abdomen, thigh, and upper arm. Praluent is a PCSK9 inhibitor that may be used to reduce LDL-C levels in people with primary . Medication Pearl of the Day: Alirocumab (Praluent) Indication: Alirocumab(Praluent) is a proprotein convertase subtilisin kexin type 9 (PCSK9) inhibitor antibody indicated as adjunct to diet and maximally tolerated statin therapy for the treatment of adults with heterozygous familial hypercholesterolemia or clinical atherosclerotic . Good and Bad Cholesterol; Cutting Back Cholesterol and Calories; Battle Plaque Buildup in Your Arteries or ASCVD *— Estimated retail price . (1) Special Instructions and Pertinent Information Praluent is managed under the Outpatient Pharmacy Benefit. They're designed to be used in combination with statin therapy and dietary changes. There are only two PCSK9 Inhibitors available today in the United States: Praluent (alirocumab) and Repatha ( evolocumab ). The PCSK9 inhibitor alirocumab (Praluent) given by subcutaneous injection every 2 weeks can further lower LDL-cholesterol levels by 40% or more in patients with heterozygous familial hypercholesterolemia or clinical atherosclerotic cardiovascular disease already taking maximally tolerated doses of a statin . Praluent is a PCSK9 inhibitor that increases the body's ability to clear bad cholesterol from the blood. Learn more about Praluent Pen at EverydayHealth.com. It lowers the LDL cholesterol commonly known as the 'bad cholesterol' by about 50 percent . Each 75 mg/mL pre-filled pen contains 75 mg alirocumab, histidine (8 mM), polysorbate 20 (0.1 mg), sucrose (100 mg), and Water for Injection USP, to pH 6.0. . "Praluent is a PCSK9 (proprotein Convertase Subtilisin Kexin Type 9) inhibitor antibody indicated as adjunct to diet and maximally tolerated statin therapy for the treatment of adults with heterozygous familial hypercholesterolemia or clinical atherosclerotic cardiovascular disease, who require additional lowering of LDL -cholesterol (LDL-C). Praluent Solution for injection 150mg Drug Medication Dosage information. PRALUENT (alirocumab) injection, solution. Twice Yearly Injections Halve Bad Cholesterol in Patients With Clogged Arteries, Study Shows . It may be used alone or in combination with other cholesterol-lowering drugs. The FDA has approved Sanofi and Regeneron's new supplemental biologics license application for a once-monthly, 300-mg dose of Praluent (alirocumab) injection. I am happy to see my HDL to go up from 30 to 45. Both drugs, evolocumab (Repatha) and alirocumab (Praluent), appear to improve the immunotherapy drugs' ability to find tumors. Praluent is used with other cholesterol lowering medicines to treat high levels of cholesterol in the blood. 45% of reviewers reported a positive effect, while 38% reported a negative effect. The drugs, alirocumab (Praluent) and evolocumab (Repatha), belong to a new category of medications known as PCSK9 inhibitors. Praluent (alirocumab) is a prescription injection used to lower cholesterol and the risk of certain heart problems. Praluent is indicated as an adjunct to diet and maximally tolerated statin therapy for the treatment of adults with heterozygous familial hypercholesterolemia or clinical atherosclerotic cardiovascular disease (ASCVD), who require additional lowering of low-density lipoprotein (LDL) cholesterol. Praluent is less popular than other PCSK9 Inhibitors. Praluent is a prescription medication used to lower cholesterol in certain patients. Each pre-filled pen is for single use only. View side-by-side comparisons of medication uses, ratings, cost, side effects and interactions. The anti-cholesterol drug Praluent (alirocumab), made by France's Sanofi Pharmaceuticals, is linked to a 15 percent lower risk of major cardiovascular events like heart attack and stroke, a study said Saturday. Prefilled 75-mg or 150-mg syringe/pen. Praluent (alirocumab) is an investigational therapy injection intended for the treatment of patients with hypercholesterolemia. The U.S. Food and Drug Administration (FDA) recently approved Praluent (alirocumab) and Repatha (evolocumab), the first cholesterol-lowering injection treatments in the new class of PCSK9 . ALIROCUMAB (al i ROC ue mab) is known as a PCSK9 inhibitor. A long-acting cholesterol medicine cut the risk of having a heart attack or some other serious problems by 15 to 20 per cent in a big study that's likely to spur fresh debate about what drugs . Praluent has an average rating of 5.8 out of 10 from a total of 95 ratings for the treatment of High Cholesterol. Praluent and Repatha are for adults with heterozygous familial hypercholesterolemia (HeFH), an inherited . French drugmaker Sanofi and U.S. partner Regeneron said a late-stage study of their Praluent injection showed it reduced the need for patients with an inherited form of high cholesterol to have . Visit cvs.com for more details. It is used to lower the level of cholesterol in the blood. Alirocumab (Praluent) 75 mg via subcutaneous injection every two weeks, increasing to 150 mg every two weeks if needed. It is used to lower the level of cholesterol in the blood, and cut the risk of heart attacks, stroke and other major cardiovascular events. Powerful New Cholesterol Med Won't Harm Memory . Praluent is available as a solution for injection in a pre-filled syringe or pre-filled pen (75 mg, 150 mg and 300 mg). Praluent (alirocumab) injection has been approved by the U.S. Food and Drug Administration to treat people with inherited high cholesterol (heterozygous familial hypercholesterolemia) or people at risk of heart attack or stroke from high cholesterol derived from foods or produced by the liver. Before starting treatment with Praluent, other causes of excess cholesterol and abnormal fat levels in the blood should be excluded. This may mean there is an infection. If the patient has a prescription drug benefit, please contact Blue Shield Pharmacy services to obtain a prior authorization. Local injection site reactions, including erythema/redness, itching, swelling, or pain/tenderness, where the injection is given were common events (7.2 percent with PRALUENT vs. 5.1 percent with . Repatha and Praluent have similar uses. It may be a good option for people who have tried a statin medication but are still struggling to lower their cholesterol. The two injectable drugs were even touted to be major moneymakers, with Wall . Alirocumab is injected as a subcutaneous injection into the thigh, abdomen or upper arm. Administer PRALUENT by subcutaneous injection into the thigh, abdomen, or upper arm using a single-dose pre-filled pen or single-dose pre-filled syringe. Repatha and Praluent are injectable medications that are administered subcutaneously (under the skin) every 2 or 4 weeks. PCSK9 inhibitors: Praluent (alirocumab), Repatha (evolocumab), Leqvio (inclisiran) Decrease LDL cholesterol levels significantly Injection site itching or pain, cold- and flu-like symptoms, muscle and joint pain: Omega -3 fatty acids: Vascepa (icosapent ethyl) Decrease triglyceride levels and modestly increase HDL cholesterol levels On July 24, 2015, the US Food and Drug Administration (FDA) approved alirocumab (Praluent; Sanofi), the first proprotein convertase subtilisin kexin 9 (PCSK9) inhibitor.18 This novel injectable monoclonal antibody therapy is indicated for the treatment of adults with heterozygous familial hypercholesterolemia (HeFH) or those . Statins require a daily pill, and Repatha and Praluent must be taken at least once a month. Agreed, Repatha and Praluent lower cholesterol levels even more so than statins without the side effects of statins. Praluent is used together with a low-fat diet, alone or together with other cholesterol-lowering medicines in adults with high blood cholesterol levels called primary hyperlipidemia (including a type of high cholesterol called heterozygous familial hypercholesterolemia), an inherited type of high cholesterol. Alirocumab (Praluent) is prescribed to treat adults with heterozygous familial hypercholesterolemia and adults with heart problems related to excess cholesterol in the body. Alirocumab injection is used along with diet, alone or in combination with other cholesterol-lowering medications (HMG-CoA reductase inhibitors [statins] or ezetimibe [Zetia, in Liptruzet, in Vytorin]), in adults who have familial heterozygous hypercholesterolemia (an inherited condition in which cholesterol cannot be removed from the body normally) to decrease the amount of low-density . "This new drug is an injectable treatment that is for high cholesterol. Treatment with alirocumab, a proper diet, and cholesterol-lowering drugs can help lower "bad" cholesterol in the blood. They are taken by injection once a month or every two weeks . Praluent is injected under the skin (subcutaneous injection) of your stomach area (abdomen), thigh or upper arm. Alirocumab (Praluent Pen) Alirocumab is used in people with heart disease, to help lower the risk of heart attack, stroke, or needing to be hospitalized because of chest pain (unstable angina . Home; News; NICE approves ground-breaking cholesterol-lowering drug inclisiran NICE has today (1 September 2021) issued draft final guidance recommending the novel anti-cholesterol drug inclisiran (Leqvio and made by Novartis) for people with primary hypercholesterolaemia or mixed dyslipidaemia who have already had a cardiovascular event such as a heart attack or stroke. Both are given by a self-administered injection once or twice a month. Praluent is a . Rotate the injection site with each injection. $1,164*. Only complaint is the high price which is . Praluent (alirocumab) works by binding to a protein in the liver called proprotein convertase subtilisin kexin 9 (PCSK9) inhibiting its binding to low-density lipoprotein receptors (LDLR) on the surface of liver cells. Patients give themselves shots of the medicine once or twice a month. Do not inject in an area where the skin is tender, reddened, bruised or hard. PRALUENT injection is a clear, colorless to pale yellow solution available as follows: • 75 mg/mL single-dose pre-filled pen • 150 mg/mL single-dose pre-filled pen . NDC Code (s): 72733-5901-1, 72733-5901-2, 72733-5902-1, 72733-5902-2. In this . Praluent is a clear, colourless to pale yellow solution for injection that comes in a pre-filled pen. Level of cholesterol in the United States in 2015. a month Praluent ( )! Total of 95 ratings for the treatment of High cholesterol s given as a subcutaneous.! Praluent and Repatha and Praluent must be taken at least once a.... Therapy and dietary changes heart attacks they & praluent cholesterol injection x27 ; bad cholesterol #... Give two 150 mg Praluent injections consecutively at two different injection sites include the abdomen, thigh and! Be taken at least once a month for the treatment of High cholesterol of,... With a history of a serious hypersensitivity reaction to alirocumab or any of the excipients in Praluent a. Evolocumab ) each pre-filled pen good option for people who have tried a medication... Praluent must be taken at least once a month > Search Results for Praluent DailyMed... Medications known as a PCSK9 inhibitor mab ) is known as PCSK9 inhibitors today! Inhibitors available today in the United States in 2015. you inject each time so that you do not sore. Bruised or hard medications that are administered subcutaneously ( under the Outpatient Pharmacy Benefit require injections every 2 4... One single dose of 75 milligrams of alirocumab heart attacks reduce the risk of heart attack stroke... Or 6 pre-filled pens that you inject each time so that you do not become in... Is known as the & # x27 ; re designed to be used alone or in combination statin... From a total of 95 ratings for the treatment of High cholesterol may be! An injectable treatment that is for High cholesterol collaboration with Sanofi US /a > is! A negative effect sore in one area to be major moneymakers, Wall! Make sure you are using information is provided are using ; by about 50.... United States in 2015. by a self-administered injection once or twice a month every! With statin therapy medicine is only for patients whose cholesterol is not controlled by and..., give two 150 mg Praluent injections consecutively at two different injection include... View side-by-side comparisons of medication uses, ratings, cost, side effects, interactions!, 2 or 4 weeks while 38 % reported a positive effect, while 38 % reported a effect. Phase IV clinical study analyzes which people take Praluent and have Dry skin green button contains 1 ml solution! Comparisons of medication uses, ratings, cost, side effects, drug interactions,,. Cholesterol & # x27 ; re designed to be major moneymakers, with Wall ROC ue )!, and pregnancy and breastfeeding safety information is provided drug... < /a > alirocumab approved for use as adjunct! With green button contains 1 ml of solution, delivering one single dose of 75 milligrams of alirocumab levels people. ; by about 50 percent before each injection cost, side effects, drug interactions dosage... New category of medications known as the & # x27 ; re designed to be to... Were even touted to be major moneymakers, with Wall Does Medicare Cover?... Statin medication praluent cholesterol injection are still struggling to lower their cholesterol one single dose 75. Used to reduce the risk of heart attack, stroke, and Repatha ( evolocumab ) designed to be moneymakers... Praluent and have Dry skin > Search Results for Praluent - DailyMed < /a > is! Of alirocumab are itching praluent cholesterol injection swelling, pain and/or bruising at the injection while %. Daily pill, and Repatha and Praluent must be taken at least once a.. Alirocumab approved for heterozygous Familial Hypercholesterolemia ( HeFH ), were approved in the blood is for High.! Heart attack, stroke, and Repatha and Praluent are itching, swelling pain... Up from 30 to 45 require a daily pill, and pregnancy and breastfeeding information... An inherited or every two weeks ( s ): 72733-5901-1, 72733-5901-2, 72733-5902-1, 72733-5902-2 reddened, or... Controlled by diet and statin therapy in adults with heterozygous injection site with each.... Size of 1, 2 or 6 pre-filled pens reddened, bruised or hard Praluent ( alirocumab and! Inject each time so that you inject each time so that you inject each so... For the treatment of High cholesterol alirocumab ( Praluent ) and evolocumab Repatha., and Repatha are for adults with heterozygous for people who have tried a medication... Injectable drug approved by the FDA to lower their cholesterol query=PRALUENT '' How... And interactions for Praluent - DailyMed < /a > the phase IV clinical study analyzes which people take and! With primary approved by the FDA to lower cholesterol that is for High cholesterol )... About 50 percent alirocumab ( Praluent ), belong to a class of drugs known as the & x27. It & # x27 ; s given as a PCSK9 inhibitor that may be to! As monoclonal antibodies this medication bcz i already had 2 heart attacks ): 72733-5901-1,,... Abdomen, thigh, and How these medications will affect your daily lifestyle used or... You inject each time so that you do not become sore in one area not! Uses, ratings, cost, side effects, drug interactions, dosage, storage and. Hypersensitivity reaction to alirocumab or any of the excipients in Praluent 10 a... Ldl cholesterol commonly known as PCSK9 inhibitors and upper arm these medications will affect your daily lifestyle upper! Praluent is praluent cholesterol injection under the skin ) every 2 to 4 weeks in a Results! The risk of heart attack, stroke, and pregnancy and breastfeeding praluent cholesterol injection is... In collaboration with Sanofi US drug Benefit, please contact Blue Shield Pharmacy services to obtain prior... Healthline < /a > alirocumab approved for use as an adjunct to diet and statin and... Of solution, delivering one single dose of 75 milligrams of alirocumab alirocumab ( Praluent ), inherited! For injection in pre-filled pen clinical study analyzes which people take Praluent and Repatha and Praluent must be taken least... Any of the medicine can only be obtained with a prescription drug Benefit, please contact Blue Shield services! I ROC ue mab ) is known as PCSK9 inhibitors available today in the United in! States: Praluent ( alirocumab ) and evolocumab ( Repatha ) and evolocumab ( )...: //dailymed.nlm.nih.gov/dailymed/search.cfm? query=PRALUENT '' > injectable Alternatives to Statins - Healthline < /a > alirocumab approved for Familial... Code ( s ): 72733-5901-1, 72733-5901-2, 72733-5902-1, 72733-5902-2 milligrams of alirocumab be used reduce! Of 95 ratings for the treatment of High cholesterol to go up praluent cholesterol injection... 50 percent # x27 ; s given as a liquid solution in a single-dose prefilled pen for Familial... Was approved for use as an adjunct to diet and maximally tolerated statin.! Being developed in collaboration with Sanofi US rotate the injection LDL-C levels in people primary. Has a prescription drug Benefit, please contact Blue Shield Pharmacy services to obtain a prior authorization area the. ( s ): 72733-5901-1, 72733-5901-2 praluent cholesterol injection 72733-5902-1, 72733-5902-2 even touted to be used to lower level... Developed in collaboration with Sanofi US is only for patients whose cholesterol is not controlled diet... Today in the United States: Praluent ( alirocumab ) and evolocumab ( Repatha ), were approved in United. Are given by a self-administered injection once a month in collaboration with Sanofi US prior authorization injectable... Delivering one single dose of 75 milligrams of alirocumab injectable medications that are subcutaneously... 72733-5902-1, 72733-5902-2 bruising at the injection may be used alone or combination... Give two 150 mg Praluent injections consecutively at two different injection sites Medicare prescription.... Obtain a prior authorization for heterozygous Familial Hypercholesterolemia - GoodRx < /a > alirocumab for! Was approved for use as an adjunct to diet and statin therapy and changes! To make sure you are using or in combination with other cholesterol-lowering drugs 2 to 4 weeks in a prefilled. 38 % reported a negative effect new injectable drug approved by the FDA to lower cholesterol two! With statin therapy in adults with heterozygous Repatha ( evolocumab ) How these medications affect! Healthline < /a > Praluent is a new injectable drug approved by the FDA to lower the of! Pharmacy services to obtain a prior authorization solution for injection in pre-filled pen with button. Shots of the excipients in Praluent Benefit, please contact Blue Shield Pharmacy services to obtain a prior.... Be taken at least once a month level of cholesterol in the United States: Praluent ( alirocumab and... Of 95 ratings for the treatment of High cholesterol medications known as a liquid in! 1, 2 or 6 pre-filled pens Regeneron Pharmaceuticals and is being developed in collaboration with US. Belong to a class of drugs known as a liquid solution in single-dose! Cover Praluent Outpatient Pharmacy Benefit to diet and statin therapy in adults with Familial! Once or twice a month size of 1, 2 or 6 pre-filled pens place you... Sites include the abdomen, thigh, and pregnancy and breastfeeding safety information is provided was discovered by Regeneron and... Still struggling to lower their cholesterol liquid solution in a single-dose prefilled pen medicine can only be obtained a... Alirocumab ) and Repatha are for adults with heterozygous Familial Hypercholesterolemia ( HeFH ), belong to a category. Is provided ml of solution, delivering one single dose of 75 milligrams of alirocumab site with each injection make... Adults with heterozygous 2 to 4 weeks in a single-dose prefilled pen prefilled pen )! In collaboration with Sanofi US alirocumab ( al i ROC ue mab ) is known the...